Tsuji K, Tsubouchi H, Yasumura K, Matsumoto M, Ishikawa H
Microbiological Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Bioorg Med Chem. 1996 Dec;4(12):2135-49. doi: 10.1016/s0968-0896(96)00217-9.
A series of cephalosporins, 2-isocephems, and 2-oxaisocephems with C-3' catechol-containing (pyridinium-4-thio)methyl groups and 2-isocephems with C-7 catechol related aromatics have been prepared and evaluated for antimicrobial activity. It turns out that these compounds have highly potent activity against Gram-negative bacteria, especially resistant pathogens such as Pseudomonas aeruginosa. The most active compound of the series was (6S,7S)-7-[2-(2-aminothiazol-4-yl)-2-[(Z)-[(1,5-dihydroxy-4-pyr idon-2-yl) methoxy]imino]acetamido]-3-[[[(4-methyl-5-carboxymethyl)thiazol-2- yl] thio]methyl]-8-oxo-1-aza-4-thiabicyclo [4.2.0] oct-2-ene-2-carboxylic acid which exhibited potent in vitro activity against clinically isolated P, aeruginosa and Acinetobacter baumanii which is also resistant to many anti-infectives, and good in vivo efficacy against clinically isolated P aeruginosa.
已经制备了一系列具有含C-3'儿茶酚的(吡啶-4-硫基)甲基的头孢菌素、2-异头孢菌素和2-氧杂异头孢菌素,以及具有C-7儿茶酚相关芳烃的2-异头孢菌素,并对其抗菌活性进行了评估。结果表明,这些化合物对革兰氏阴性菌具有高效活性,尤其是对铜绿假单胞菌等耐药病原体。该系列中活性最高的化合物是(6S,7S)-7-[2-(2-氨基噻唑-4-基)-2-[[(Z)-[(1,5-二羟基-4-吡啶酮-2-基)甲氧基]亚氨基]乙酰胺基]-3-[[[(4-甲基-5-羧甲基)噻唑-2-基]硫基]甲基]-8-氧代-1-氮杂-4-硫杂双环[4.2.0]辛-2-烯-2-羧酸,它对临床分离的铜绿假单胞菌和鲍曼不动杆菌表现出强大的体外活性,鲍曼不动杆菌对许多抗感染药物也具有耐药性,并且对临床分离的铜绿假单胞菌具有良好的体内疗效。